Paz J Vellanki

FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma

Jiang Liu, Martha Donoghue, R. Pazdur, 2021, Clinical Cancer Research.

FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non–Small Cell Lung Cancer, a Collaborative Project Orbis Review

Jiang Liu, R. Pazdur, U. Rohr, 2021, Clinical Cancer Research.

Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes.

R. Mehra, R. Donehower, M. Holdhoff, 2019, Journal of oncology practice.

Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study.

D. Howard, B. Powell, T. Pardee, 2021, Leukemia research.